Join Early Retirement Today
Thread Tools Search this Thread Display Modes
Prostate Cancer: Can New Tests Reduce Unnecessary Treatment?
Old 06-02-2013, 09:19 PM   #1
Recycles dryer sheets
Join Date: Aug 2009
Posts: 116
Prostate Cancer: Can New Tests Reduce Unnecessary Treatment?

Prostate Cancer: Can New Tests Reduce Unnecessary Treatment?

Two new genetic tests may help better predict which prostate cancers are aggressive and need immediate treatment, and which do not need treatment right away, researchers say.

One test, called Prolaris and manufactured by Myriad Genetics, looks for specific genes that control a cancer cell's abilities to divide and multiply. Patients receive a score (between -3 and 3) that indicates how aggressive their cancer is.
The other test, called Oncotype DX Prostate Cancer Test and manufactured by Genomic Health, was released earlier this month and is also marketed as a test to predict prostate-cancer aggressiveness.

But experts say that although these tests do seem to help predict cancer outcomes, their usefulness to doctors and patients remains to be seen. Researchers still need to determine "how much added information these tests really provide, and how often it's going to really change how we manage a patient," said Dr. Judd Moul, director of the Duke Prostate Center in Durham, N.C.
In a review of five studies, researchers at Myriad found that the Prolaris test, in combination with standard methods of assessing prostate cancer including the PSA test and the Gleason score could better predict whether patients would die from prostate cancer than the PSA test and Gleason scorecould alone.

Both tests are expensive, and are not always covered by insurance. The Prolaris test costs $3,400, and Oncotype DX costs $3,820.

tjscott0 is offline   Reply With Quote
Join the #1 Early Retirement and Financial Independence Forum Today - It's Totally Free!

Are you planning to be financially independent as early as possible so you can live life on your own terms? Discuss successful investing strategies, asset allocation models, tax strategies and other related topics in our online forum community. Our members range from young folks just starting their journey to financial independence, military retirees and even multimillionaires. No matter where you fit in you'll find that is a great community to join. Best of all it's totally FREE!

You are currently viewing our boards as a guest so you have limited access to our community. Please take the time to register and you will gain a lot of great new features including; the ability to participate in discussions, network with our members, see fewer ads, upload photographs, create a retirement blog, send private messages and so much, much more!

Old 06-03-2013, 07:15 AM   #2
Thinks s/he gets paid by the post
grasshopper's Avatar
Join Date: Oct 2010
Posts: 1,740
Thanks, I had not seen this. I have been diagnosed with clinically insignificant PC, and I am choosing to carefully monitor the disease and watch my diet. In my personal research there are many folks that can't coexist with PC and need surgery or some other treatment. For those folks I think most urologist would have a hard time convincing them to try active surveillance, no matter what the test results are.
For me experiences are not good or bad, just different
grasshopper is offline   Reply With Quote

Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are Off
Pingbacks are Off
Refbacks are Off


All times are GMT -6. The time now is 11:33 PM.
Powered by vBulletin® Version 3.8.8 Beta 1
Copyright ©2000 - 2018, vBulletin Solutions, Inc.